OGEN ORAGENICS INC: institutional ownership and insider trading
19 funds reported holding $307K of ORAGENICS INC in their latest 13F filings; in Q2 2026 funds net sold $71.2K, with 2 new positions and 5 funds selling out; over the last 12 months insiders bought $0 and sold $197 on the open market.
Largest institutional holders of OGEN
- CLEAR STREET LLC — $270K
- GEODE CAPITAL MANAGEMENT, LLC — $13.8K
- 25 LLC — $11.4K
- JANE STREET GROUP, LLC — $7.41K
- Tower Research Capital LLC (TRC) — $2.64K
- St. Johns Investment Management Company, LLC — $1.12K
- BlackRock, Inc. (BLK) — $408
- UBS Group AG (UBS) — $373
- WELLS FARGO & COMPANY/MN (WFC, WFCNP, WFC-PA, WFC-PC, WFC-PD, WFC-PL, WFC-PY, WFC-PZ) — $20
- HARBOUR INVESTMENTS, INC. — $20
Recent OGEN insider trades
- Dec 12, 2025: Telling Fred sold 210 shares ($197)
- Jun 18, 2025: Odyssey Health, Inc. sold 7,044 shares ($30.4K)
- Jun 16, 2025: Odyssey Health, Inc. sold 10,000 shares ($43.6K)
- Dec 6, 2024: Dunton Alan W sold 66 shares ($24)
5%+ owners
- Five Narrow Lane LP: 10.0% (Schedule 13G, filed Jul 2, 2025)
- SABBY MANAGEMENT, LLC: 9.9% (Schedule 13G, filed Jan 21, 2026)